A detailed history of Ifm Investors Pty LTD transactions in Incyte Corp stock. As of the latest transaction made, Ifm Investors Pty LTD holds 36,744 shares of INCY stock, worth $2.79 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,744
Previous 38,970 5.71%
Holding current value
$2.79 Million
Previous $2.36 Million 2.79%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$57.33 - $68.61 $127,616 - $152,725
-2,226 Reduced 5.71%
36,744 $2.43 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $58,089 - $72,356
1,135 Added 3.0%
38,970 $2.36 Million
Q1 2024

Apr 22, 2024

BUY
$56.55 - $66.59 $2,714 - $3,196
48 Added 0.13%
37,835 $2.16 Million
Q3 2023

Oct 26, 2023

SELL
$57.77 - $65.93 $98,844 - $112,806
-1,711 Reduced 4.33%
37,787 $2.18 Million
Q2 2023

Jul 27, 2023

BUY
$60.95 - $75.51 $356,191 - $441,280
5,844 Added 17.36%
39,498 $2.46 Million
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $225,368 - $276,006
3,209 Added 10.54%
33,654 $2.43 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $53,072 - $66,446
790 Added 2.66%
30,445 $2.45 Million
Q1 2022

Apr 13, 2022

BUY
$66.02 - $79.71 $274,577 - $331,513
4,159 Added 16.31%
29,655 $2.36 Million
Q2 2021

Jul 16, 2021

BUY
$79.87 - $87.53 $375,229 - $411,215
4,698 Added 22.59%
25,496 $2.15 Million
Q1 2021

May 05, 2021

BUY
$76.02 - $100.5 $231,784 - $306,424
3,049 Added 17.18%
20,798 $1.69 Million
Q4 2020

Jan 13, 2021

BUY
$80.74 - $97.7 $247,306 - $299,255
3,063 Added 20.86%
17,749 $1.54 Million
Q3 2020

Oct 16, 2020

BUY
$85.07 - $109.69 $89,323 - $115,174
1,050 Added 7.7%
14,686 $1.32 Million
Q2 2020

Jul 13, 2020

SELL
$74.18 - $108.93 $407,248 - $598,025
-5,490 Reduced 28.7%
13,636 $1.42 Million
Q1 2020

Apr 09, 2020

SELL
$63.18 - $85.97 $50,164 - $68,260
-794 Reduced 3.99%
19,126 $1.38 Million
Q4 2019

Jan 13, 2020

SELL
$73.04 - $95.72 $49,448 - $64,802
-677 Reduced 3.29%
19,920 $1.74 Million
Q3 2019

Nov 01, 2019

BUY
$72.82 - $86.52 $613,872 - $729,363
8,430 Added 69.29%
20,597 $1.53 Million
Q1 2019

Apr 18, 2019

BUY
$63.56 - $88.17 $111,039 - $154,032
1,747 Added 16.77%
12,167 $1.05 Million
Q4 2018

Jan 23, 2019

BUY
$58.5 - $69.94 $67,158 - $80,291
1,148 Added 12.38%
10,420 $663,000
Q3 2018

Oct 22, 2018

BUY
$61.75 - $74.23 $76,878 - $92,416
1,245 Added 15.51%
9,272 $641,000
Q2 2018

Jul 09, 2018

BUY
$60.85 - $83.98 $155,350 - $214,400
2,553 Added 46.64%
8,027 $538,000
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $51,331 - $62,405
618 Added 12.73%
5,474 $456,000
Q3 2017

Nov 16, 2017

BUY
$109.15 - $138.27 $30,234 - $38,300
277 Added 6.05%
4,856 $567,000
Q2 2017

Nov 21, 2017

BUY
N/A
4,579 New
4,579 $577,000
Q2 2017

Aug 10, 2017

SELL
N/A
-3,493 Closed
0 $0
Q1 2017

Nov 21, 2017

BUY
N/A
3,493
3,493 $467,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.